Evaluation of pharmacokinetics and safety of ponatinib in subjects with chronic hepatic impairment and matched healthy subjects
Crossref DOI link: https://doi.org/10.1007/s00280-014-2511-z
Published Online: 2014-06-17
Published Print: 2014-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Narasimhan, Narayana I.
Dorer, David J.
Davis, Jeffrey
Turner, Christopher D.
Marbury, Thomas C.
Sonnichsen, Daryl
Text and Data Mining valid from 2014-06-17